
NASDAQHealthcareMedical - Instruments & Supplies
最新数据
US$74.5639
+US$0.1539 · +0.21%
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
常规交易时段
US$74.5639
+US$0.1539 · +0.21%
盘中时间采用ET。市场数据可能有所延迟。
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
日内区间
当前US$74.5639
52周区间
当前US$74.5639
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
81
深度低估
情绪
53
多空交织
风险
40
中等风险
动量
51
中性
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
日内区间
当前US$74.5639
52周区间
当前US$74.5639
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 3852万 USD | 4090.3万 USD | 5022.4万 USD | 5228.1万 USD | 4905.4万 USD |
| 销货成本 | 1864.5万 USD | 1676万 USD | 2018.6万 USD | 2008.5万 USD | 1813.7万 USD |
| 毛利 | 1987.5万 USD | 2414.3万 USD | 3003.8万 USD | 3219.6万 USD | 3091.7万 USD |
| 研究与开发 | 66.8万 USD | 81.3万 USD | 56万 USD | 49.3万 USD | 52.6万 USD |
| 销售、一般及管理费用 | 780.5万 USD | 556.7万 USD | 1270.1万 USD | 1191.3万 USD | 1151.1万 USD |
| 营业费用 | 847.3万 USD | 1054.9万 USD | 1326.1万 USD | 1240.6万 USD | 1203.7万 USD |
| 利息收入 | — | 336.7万 USD | — | 66.1万 USD | 16.6万 USD |
| 折旧和摊销 | 300.8万 USD | 284.6万 USD | 636.8万 USD | 708.2万 USD | 728.4万 USD |
| 营业利润 | 1140.2万 USD | 1359.4万 USD | 1677.7万 USD | 1979万 USD | 1888万 USD |
| 净利润 | 1128.6万 USD | 1387.4万 USD | 1663.5万 USD | 1647.3万 USD | 1478.8万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
年度分割调整后的每股现金分配。
US$1.225
2025年(完整年度)-57.1% 自从 2021
2026年(部分年度):US$0.93
US$2.855
2,021
US$1.165
2,022
US$1.185
2,023
US$1.205
2,024
US$1.225
2,025
US$0.93
2,026*
* 在现有股息历史记录中,该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年9月17日 | US$0.31Quarterly | 2026年9月17日 | 2026年10月5日 |
股息 | 2026年6月17日 | US$0.31Quarterly | 2026年6月17日 | 2026年7月3日 |
股息 | 2026年3月17日 | US$0.31Quarterly | 2026年3月17日 | 2026年4月3日 |
股息 | 2025年12月16日 | US$0.31Quarterly | 2025年12月16日 | 2026年1月5日 |
股息 | 2025年9月17日 | US$0.305Quarterly | 2025年9月17日 | 2025年10月2日 |
股息 | 2025年6月16日 | US$0.305Quarterly | 2025年6月16日 | 2025年7月3日 |
除息 2026年9月17日
US$0.31
Quarterly
2026年9月17日登记 · 支付日 2026年10月5日
除息 2026年6月17日
US$0.31
Quarterly
2026年6月17日登记 · 支付日 2026年7月3日
除息 2026年3月17日
US$0.31
Quarterly
2026年3月17日登记 · 支付日 2026年4月3日
除息 2025年12月16日
US$0.31
Quarterly
2025年12月16日登记 · 支付日 2026年1月5日
除息 2025年9月17日
US$0.305
Quarterly
2025年9月17日登记 · 支付日 2025年10月2日
除息 2025年6月16日
US$0.305
Quarterly
2025年6月16日登记 · 支付日 2025年7月3日
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI695.57万0.00%2.3万亿 USD0.03%US$380.65-0.24%
iShares Russell 2000 ETFIWM499.51万0.01%787.4亿 USD0.19%US$276.26-0.59%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV401.98万0.01%268.33亿 USD0.33%US$38.025+0.12%
Dimensional - US Targeted Value ETFDFAT305.25万0.01%302.16亿 USD0.33%US$67.505+0.13%
Dimensional - US Small Cap ETFDFAS239.94万0.01%338.04亿 USD0.31%US$77.955-0.28%
Vanguard Extended Market ETFVXF236.93万0.00%954亿 USD0.05%US$232.03-0.64%
U.S. Micro Cap Portfolio ETFDFMC225.86万0.03%75.44亿 USD0.43%US$57.5324-0.29%
iShares Russell 2000 Value ETFIWN192.4万0.01%137.49亿 USD0.24%US$210.48-0.29%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Dimensional - US Targeted Value ETFDFAT
Dimensional - US Small Cap ETFDFAS
Vanguard Extended Market ETFVXF
U.S. Micro Cap Portfolio ETFDFMC
iShares Russell 2000 Value ETFIWNAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。